Therapeutic cloning: The ethical limits

Journal Article · Thu Sep 01 00:00:00 EDT 2005 · Toxicology and Applied Pharmacology

DOI:https://doi.org/10.1016/j.taap.2004.11.034· OSTI ID:20721980

Whittaker, Peter A ^[1]

---

1. ESRC Centre for Economic and Social Aspects of Genomics, Lancaster University, Furness College, Lancaster LA1 4YG (United Kingdom)

A brief outline of stem cells, stem cell therapy and therapeutic cloning is given. The position of therapeutic cloning with regard to other embryonic manipulations - IVF-based reproduction, embryonic stem formation from IVF embryos and reproductive cloning - is indicated. The main ethically challenging stages in therapeutic cloning are considered to be the nuclear transfer process including the source of eggs for this and the destruction of an embryo to provide stem cells for therapeutic use. The extremely polarised nature of the debate regarding the status of an early human embryo is noted, and some potential alternative strategies for preparing immunocompatible pluripotent stem cells are indicated.

• OSTI ID: 20721980
• Journal Information: Toxicology and Applied Pharmacology, Vol. 207, Issue 2,suppl.1; Conference: ICT X 2004: 10. international congress of toxicology: Living in a safe chemical world, Tampere (Finland), 11-15 Jul 2004; Other Information: DOI: 10.1016/j.taap.2004.11.034; PII: S0041-008X(05)00356-X; Copyright (c) 2005 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); ISSN 0041-008X
• Country of Publication: United States
• Language: English

Related Subjects

60 APPLIED LIFE SCIENCES
CLONING
EGGS
EMBRYOS
ETHICAL ASPECTS
REPRODUCTION
STEM CELLS
THERAPEUTIC USES